The O.C.

GivBux Introduces Groundbreaking Super App: A Fusion of Digital Commerce and Philanthropy

Retrieved on: 
Thursday, August 24, 2023
Networking hardware, Organic, Old Navy, Personal Data Privacy and Security Act of 2009, Delta Air Lines, The O.C., Tencent, Safe harbor, AMC, Amazon, Super-app, WeChat, Collection, Nature, OTC, Transport, Petco, IBN, Mobile phone, Online shopping

As the first and only app of its nature, the GivBux Super App weaves together brands, consumers and charities into a unified economic ecosystem.

Key Points: 
  • As the first and only app of its nature, the GivBux Super App weaves together brands, consumers and charities into a unified economic ecosystem.
  • The GivBux Super App stands out as a user-friendly shopping tool, enabling swift purchases at over 100 national retailers, alongside a steadily increasing array of local ones.
  • True to GivBux Inc.'s commitment to "give back," users can specify their preferred charities within the app.
  • The GivBux Super App is a multi-functional platform, encapsulating several services beyond its primary features.

Fintech Leaders, GoLogiq and GammaRey, Plan to Combine Forces in $320 Million Merger

Retrieved on: 
Thursday, December 15, 2022
Acquisition, Millennials, Science and technology in Asia, Publishing, Generation Z, Bain & Company, OTC Markets Group, Touch 'n Go eWallet, Annual report, OTCQX, NYSE, Big data, Security (finance), Government, Business, OTC, 8-K, The O.C., Digital, Gen, Consumer, Safe harbor, FINRA, Digital economy, Growth, COVID-19, Cryptocurrency, Real estate, Bank, Audit

NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- GoLogiq, Inc. (OTC:GOLQ), a U.S.-based global provider of fintech and consumer data analytics, has signed a mutual non-binding letter of intent to acquire GammaRey, Inc., a privately-held fintech ecosystem for the New World Digital Economy.  

Key Points: 
  • Under the terms of the proposed agreement, GoLogiq will acquire GammaRey as a wholly owned subsidiary in an all-stock transaction.
  • GoLogiq would issue common shares to GammaRey shareholders valued at $320 million based on the pricing of $3.00 per share.
  • The transaction would follow GoLogiq’s spin-off of assets from Logiq, Inc. (OTCQX: LGIQ) which was completed earlier this year.
  • GoLogiq would also plan to apply for an uplisting to a listed exchange, such as Nasdaq or the NYSE.

Logiq and MediaJel Align to Provide Powerful Marketing Tools and Enhance Consumer Targeting and Reach Companies Expect Stronger Competitive Advantages, Brand Equity and Enterprise Value

Retrieved on: 
Tuesday, December 13, 2022
Acquisition, Annual report, OTCQX, Advertising, Security (finance), Push Interactions, The O.C., Safe harbor, Legislation, Esports, Cannabis, ROI, Growth, COVID-19, Video game console, Online shopping, Audit

The strategic alliance is intended to create mutually beneficial opportunities for both companies to provide more powerful technological benefits to their customers, thereby growing their respective top lines across their proprietary platforms.

Key Points: 
  • The strategic alliance is intended to create mutually beneficial opportunities for both companies to provide more powerful technological benefits to their customers, thereby growing their respective top lines across their proprietary platforms.
  • Accordingly, management and the Boards of Directors of both companies anticipate the alliance will increase competitive advantages, enterprise value, and brand equity.
  • By combining proprietary digital attribution with comprehensive industry integrations, MediaJel is able to deliver clear, transparent marketing results from impression to transaction.
  • Any forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement.

89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of NASH in The Lancet Gastroenterology & Hepatology

Retrieved on: 
Monday, December 12, 2022
Liver, Steatosis, Health, Inflammation, SAN, Lipid metabolism, Cardiovascular disease, Prevalence, The Lancet, Disclosure, Hepatology, FDA, Hepatocellular carcinoma, Safety, Liver transplantation, FGF21, The O.C., Half-life, Safe harbor, Liver injury, Trial of the century, Risk, MHSC, Conditional sentence, Fibrosis, Lipid, Obesity, University of California, San Diego, Fatty liver disease, Type 2 diabetes, Hypertriglyceridemia, University, COVID-19, Cirrhosis, Patient, Diabetes, NAFLD, Dietary supplement, Pharmaceutical industry

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that data from cohorts 1-6 in the the Phase 1b/2a proof-of-concept study evaluating pegozafermin for the treatment of nonalcoholic steatohepatitis (NASH) was published online in The Lancet Gastroenterology & Hepatology. Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo. Up to 88% of patients had at least a 30% reduction in hepatic fat fraction, which has been shown to correlate with reduced fibrosis progression.1,2 Furthermore, improvements in liver transaminases (measures of liver injury), measures of fibrosis and lipids were observed with pegozafermin compared to placebo. In this study, pegozafermin was well tolerated with no treatment-related serious adverse events observed.

Key Points: 
  • Study results showed statistically significant absolute reductions in hepatic fat fraction at week 13 with pegozafermin administered every week or every two weeks compared to placebo.
  • In this study, pegozafermin was well tolerated with no treatment-related serious adverse events observed.
  • The company is focused on rapidly advancing its lead candidate, pegozafermin, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG).
  • 89bio claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements.

HQGE’s Big M Entertainment Pictures Designates Development and Production Planning Locations in New Orleans, LA for Multiple Film and TV Formats

Retrieved on: 
Thursday, December 8, 2022
Nature, OTC, BMEP, The O.C., Safe harbor, Heart, Energy Independence and Security Act of 2007, Music, Film, Creative industries

The near-term agenda also includes the development of several new episodes for a separate paranormal series, title not yet released, that is currently in production by BMEP Los Angeles.

Key Points: 
  • The near-term agenda also includes the development of several new episodes for a separate paranormal series, title not yet released, that is currently in production by BMEP Los Angeles.
  • HQ Global Education, Inc. is the parent company of Big M Entertainment Pictures, Inc., a full-service film and TV production company located in the heart of Los Angeles.
  • Big M Entertainment was founded by Marvin Williams, who brings with him more than fifteen years’ experience working with music, film and TV projects covering a wide range of budgets and scope.
  • This material contains statements about expected future events and/or financial results that are forward-looking in nature and as such are by definition subject to risks and uncertainties.

Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology

Retrieved on: 
Tuesday, November 29, 2022
SAN, Safe harbor, OTC, CNBC, Nature, Organization, Information technology, Food, Life, Natural Resources, Medical Marijuana, Inc., Drug Quality and Security Act, Textile, Disease, GMP, Agriculture, Information, CBD, The O.C., Food and Drug Administration, Building material, Medical cannabis, Safety, Drug, Management, Dietary supplement

SAN DIEGO, CA, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway, has appointed two industry veterans to leadership roles within the organization; Mike Randolph as Executive Vice President and Mike Kolinski as Vice President of Information Technology.

Key Points: 
  • Mr. Randolph is a 31-year veteran of the industry bringing a combination of entrepreneurial spirit and a diverse professional background with him to Kannaway.
  • Newly appointed Vice President of Information Technology Mike Kolinski brings 25 years of industry experience, having worked in both sales and customer support roles, before taking on a leadership role in information technology where he has held the Vice President title for nearly two decades.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results

Retrieved on: 
Tuesday, November 22, 2022
Growth, SAN, Safe harbor, OTC, CNBC, Nature, Food, Medical cannabis, Partnership, Medical Marijuana, Inc., Face, Drug Quality and Security Act, Disease, International, The O.C., CBD, Food and Drug Administration, Publication, Safety, Drug

We will continue to target expansion of our brands as we work to build the worlds first truly global cannabis company.

Key Points: 
  • We will continue to target expansion of our brands as we work to build the worlds first truly global cannabis company.
  • Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties.
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Logiq Signs LOI to Acquire Privately Held Operating Company

Retrieved on: 
Friday, November 18, 2022
COVID-19, Growth, Safe harbor, Digital, SPAC, OTCQX, Legislation, Annual report, Security (finance), NYSE, The O.C., Rock shelter, Acquisition, Risk management, Sales, Financial services, Bank, Audit

NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ) (“the Company”), a provider of digital consumer acquisition solutions, today announced that it has signed a non-binding letter of intent (“LOI”) with a privately held operating company (“PrivCo”) in which – effectively simultaneous with Logiq’s pending de-SPAC transaction with Abri SPAC I– Logiq will acquire PrivCo in a share exchange of newly issued Logiq shares for 100% of the shareholder interests of PrivCo. PrivCo will become a wholly-owned subsidiary of the Company and is expected to place executives in senior management positions.

Key Points: 
  • The transaction would be executed simultaneously with Logiqs pending Abri de-SPAC deal whereby the confidential target would be acquired to become a wholly owned subsidiary of Logiq.
  • NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc.(OTCQX: LGIQ) (the Company), a provider of digital consumer acquisition solutions, today announced that it has signed a non-binding letter of intent (LOI) with a privately held operating company (PrivCo) in which effectively simultaneous with Logiqs pending de-SPAC transaction with Abri SPAC I Logiq will acquire PrivCo in a share exchange of newly issued Logiq shares for 100% of the shareholder interests of PrivCo.
  • PrivCo will become a wholly-owned subsidiary of the Company and is expected to place executives in senior management positions.
  • The recent announcement of the Abri SPAC I (special purpose acquisition company) transaction for Logiq opens a possibility for Logiq to acquire PrivCo simultaneous with the DataLogiq business being acquired by Abri.

Logiq Signs LOI to Acquire Privately Held Operating Company

Retrieved on: 
Thursday, November 17, 2022
COVID-19, Growth, Safe harbor, Digital, SPAC, OTCQX, Legislation, Annual report, Security (finance), NYSE, The O.C., Rock shelter, Acquisition, Risk management, Sales, Financial services, Bank, Audit

NEW YORK, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ) (“the Company”), a provider of digital consumer acquisition solutions, today announced that it has signed a non-binding letter of intent (“LOI”) with a privately held operating company (“PrivCo”) in which – effectively simultaneous with Logiq’s pending de-SPAC transaction with Abri SPAC I (Nasdaq: ASPA) – Logiq will acquire PrivCo in a share exchange of newly issued Logiq shares for 100% of the shareholder interests of PrivCo. PrivCo will become a wholly-owned subsidiary of the Company and is expected to place executives in senior management positions.

Key Points: 
  • NEW YORK, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc.(OTCQX: LGIQ) (the Company), a provider of digital consumer acquisition solutions, today announced that it has signed a non-binding letter of intent (LOI) with a privately held operating company (PrivCo) in which effectively simultaneous with Logiqs pending de-SPAC transaction with Abri SPAC I (Nasdaq: ASPA) Logiq will acquire PrivCo in a share exchange of newly issued Logiq shares for 100% of the shareholder interests of PrivCo.
  • PrivCo will become a wholly-owned subsidiary of the Company and is expected to place executives in senior management positions.
  • The recent announcement of the Abri SPAC I (special purpose acquisition company) transaction for Logiq opens a possibility for Logiq to acquire PrivCo simultaneous with the DataLogiq business being acquired by Abri.
  • Large institutional shareholders including an American fund management company, Swiss bank and Asian conglomerate
    Logiq Chief Executive Officer, Brent Suen, commented, We are excited about the late-stage discussions underway with this privately held operating company to complete a transaction that is win-win for both companies shareholders.

Logiq to Host Third Quarter 2022 Financial Results Conference Call

Retrieved on: 
Monday, November 14, 2022
The O.C., Safe harbor, Acquisition, Security (finance), Annual report, Growth, COVID-19, OTCQX, Legislation, Risk management, Audit

NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning digital consumer acquisition solutions, today announced it will hold a conference call to review its third quarter 2022 financial and operational results, ended September 30, on Tuesday, November 15, 2022, at 10:30 a.m. Eastern time.

Key Points: 
  • NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning digital consumer acquisition solutions, today announced it will hold a conference call to review its third quarter 2022 financial and operational results, ended September 30, on Tuesday, November 15, 2022, at 10:30 a.m. Eastern time.
  • The Company will release its financial results in a press release prior to the call.
  • Logiq, Inc. is a U.S.-based leading global provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising.
  • It provides data-driven, end-to-end marketing through its results solution or providing software to access data by activating campaigns across multiple channels.